PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17604344-1	2008	Epirubicin, an antineoplastic drug, is considered to be taken up by tumor cells via a common carrier by facilitated diffusion and is then pumped out in an energy-dependent manner because epirubicin is a substrate for P-glycoprotein (P-gp).	Epirubicin	0-10	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	217-231	
17604344-1	2008	Epirubicin, an antineoplastic drug, is considered to be taken up by tumor cells via a common carrier by facilitated diffusion and is then pumped out in an energy-dependent manner because epirubicin is a substrate for P-glycoprotein (P-gp).	Epirubicin	0-10	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	233-237	
17604344-1	2008	Epirubicin, an antineoplastic drug, is considered to be taken up by tumor cells via a common carrier by facilitated diffusion and is then pumped out in an energy-dependent manner because epirubicin is a substrate for P-glycoprotein (P-gp).	Epirubicin	187-197	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	217-231	
17604344-1	2008	Epirubicin, an antineoplastic drug, is considered to be taken up by tumor cells via a common carrier by facilitated diffusion and is then pumped out in an energy-dependent manner because epirubicin is a substrate for P-glycoprotein (P-gp).	Epirubicin	187-197	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	233-237